Guggenheim Capital’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,497
| Closed | -$256K | – | 1585 |
|
|
2025
Q1 | $256K | Sell |
34,497
-6,348
| -16% | -$47.2K | ﹤0.01% | 1455 |
|
|
2024
Q4 | $245K | Sell |
40,845
-10,093
| -20% | -$60.6K | ﹤0.01% | 1518 |
|
|
2024
Q3 | $261K | Sell |
50,938
-2,390
| -4% | -$12.2K | ﹤0.01% | 1666 |
|
|
2024
Q2 | $193K | Sell |
53,328
-1,547
| -3% | -$5.6K | ﹤0.01% | 1766 |
|
|
2024
Q1 | $176K | Sell |
54,875
-1,974
| -3% | -$6.34K | ﹤0.01% | 1809 |
|
|
2023
Q4 | $279K | Sell |
56,849
-351
| -0.6% | -$1.72K | ﹤0.01% | 1699 |
|
|
2023
Q3 | $312K | Buy |
57,200
+30,754
| +116% | +$168K | ﹤0.01% | 1607 |
|
|
2023
Q2 | $177K | Buy |
26,446
+15,306
| +137% | +$103K | ﹤0.01% | 1789 |
|
|
2023
Q1 | $98.4K | Buy |
+11,140
| New | +$98.4K | ﹤0.01% | 1876 |
|
|
2022
Q4 | – | Sell |
-18,605
| Closed | -$132K | – | 1908 |
|
|
2022
Q3 | $132K | Sell |
18,605
-978
| -5% | -$6.94K | ﹤0.01% | 1827 |
|
|
2022
Q2 | $158K | Buy |
19,583
+880
| +5% | +$7.1K | ﹤0.01% | 1974 |
|
|
2022
Q1 | $260K | Buy |
18,703
+68
| +0.4% | +$945 | ﹤0.01% | 1942 |
|
|
2021
Q4 | $523K | Sell |
18,635
-52,384
| -74% | -$1.47M | ﹤0.01% | 1672 |
|
|
2021
Q3 | $2.41M | Sell |
71,019
-2,847
| -4% | -$96.8K | 0.01% | 962 |
|
|
2021
Q2 | $3.02M | Buy |
73,866
+810
| +1% | +$33.1K | 0.02% | 880 |
|
|
2021
Q1 | $2.94M | Buy |
73,056
+17,132
| +31% | +$690K | 0.02% | 831 |
|
|
2020
Q4 | $3.31M | Buy |
+55,924
| New | +$3.31M | 0.02% | 750 |
|